Recombinant Human Fms-Related Tyrosine Kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), His-tagged
Cat.No. : | FLT1-1222H |
Product Overview : | Recombinant humanFLT1 containing amino acids 783-end and an N-terminal His tag. |
- Specification
- Gene Information
- Related Products
- Download
Cat. No. : | FLT1-1222H |
Description : | FLT1is a protein that in humans is encoded by the FLT1 gene. FLT1 belongs to thesrc gene family and is related to oncogene ROS. Like other members of thisfamily, it shows tyrosine protein kinase activity that is important for thecontrol of cell proliferation and differentiation. |
Source : | Baculovirus infectedSf9 cells |
Species : | Human |
Form : | Liquid in25 mM Tris-HCl, pH 8.0 + 100 mM NaCl + 0.05% Tween-20 + 50% glycerol + 3 mMDTT. |
Molecular Weight : | 67.5 kDa |
Specific Activity : | 170 U/mg. One unitis defined as the amount of enzyme that will transfer 1 nmol phosphate to thetyrosine substrate per minute at pH 7.4 and 30°C. Assay buffer: 50 mM HEPES,pH 7.4 + 3 mM MgCl2 + 3 mM MnCl2 + 1 mM DTT + 3 µM Na-orthovanadate + 0.1 mMATP + 30 µg/ml Poly (Glu:Tyr)4:1 substrate + 2 µg /ml recombinant FLT1. |
Storage : | Stable for 6 monthsin working aliquots at -80°C. Avoid repeated freeze-thaw cycles. |
Protein length : | 783-end |
Gene Name : | FLT1 fms-related tyrosine kinase 1(vascular endothelial growth factor/vascular permeability factor receptor) [ Homosapiens ] |
Official Symbol : | FLT1 |
Synonyms : | FLT1; fms-related tyrosinekinase 1 (vascular endothelial growth factor/vascular permeability factorreceptor); FLT; VEGFR1; FRT; vascular endothelial growth factor receptor 1;EC 2.7.10.1; VEGFR-1; Vascular permeability factor receptor; Flt-1;Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-liketyrosine kinase 1 |
Gene ID : | 2321 |
mRNA Refseq : | NM_001159920 |
Protein Refseq : | NP_001153392 |
MIM : | 165070 |
UniProt ID : | P17948 |
Chromosome Location : | 13q12 |
Pathway : | Cytokine-cytokinereceptor interaction; Endocytosis; Focal Adhesion; Glypican 1 network;HIF-2-alpha transcription factor network; Id Signaling Pathway; Neurophilininteractions with VEGF and VEGFR; Rheumatoid arthritis; S1P3 pathway; SignalTransduction; Signaling by VEGF; Signaling events mediated by VEGFR1 andVEGFR2; VEGF binds to VEGFR leading to receptor dimerization; VEGFligand-receptor interactions; VEGFR1 specific signals |
Function : | ATP binding; growth factorbinding; identical protein binding; nucleotide binding; receptor activity;transferase activity; vascular endothelial growth factor receptor activity |
Products Types
◆ Recombinant Protein | ||
Flt1-7210M | Active Recombinant Mouse Flt1 Protein, Fc-tagged | +Inquiry |
FLT1-4366H | Recombinant Human FLT1 Protein | +Inquiry |
Flt1-1785M | Active Recombinant Mouse Flt1 Protein, Fc-tagged | +Inquiry |
Flt1-49M | Recombinant Mouse Flt1 Protein, His (Fc)-Avi-tagged | +Inquiry |
FLT1-474H | Recombinant Human FLT1 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
FLT1-1207RCL | Recombinant Rat FLT1 cell lysate | +Inquiry |
FLT1-1909HCL | Recombinant Human FLT1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewthe FLT1 protein is an excellent choice for researchers due to its high quality, reliability, and the comprehensive technical support provided by the manufacturer.
The manufacturer of FLT1 protein provides excellent technical support, ensuring that researchers receive prompt assistance and guidance when encountering any challenges or difficulties.
Researchers can confidently incorporate FLT1 protein into their experiments, knowing that they have access to a reliable resource that will meet their experimental needs effectively.
Q&As (5)
Ask a questionElevated levels of soluble FLT1 have been associated with preeclampsia, a pregnancy complication. Soluble FLT1 acts as a decoy receptor, reducing the bioavailability of VEGF and contributing to vascular dysfunction.
FLT1 has been implicated in retinal diseases like diabetic retinopathy, where abnormal blood vessel growth can lead to vision impairment. Inhibiting FLT1 may help regulate angiogenesis in such conditions.
FLT1 expression is regulated by various factors, including VEGF itself, as well as hypoxia and inflammation. These factors influence the balance of angiogenic signaling.
Yes, elevated levels of soluble FLT1 have been investigated as potential biomarkers for conditions like preeclampsia, cancer, and certain cardiovascular diseases.
Yes, targeting FLT1 is a strategy for anti-angiogenic therapy. Inhibiting FLT1 can impede blood vessel formation, limiting the blood supply to tumors and potentially slowing their growth.
Ask a Question for All FLT1 Products
Required fields are marked with *
My Review for All FLT1 Products
Required fields are marked with *
Inquiry Basket